Home Tags Diabetes: Misc.

Tag: Diabetes: Misc.

September 2019 Briefing – Diabetes & Endocrinology

Here are what the editors at HealthDay consider to be the most important developments in Diabetes & Endocrinology for September 2019. This roundup includes...
Short-term use of a dipeptidyl peptidase 4 inhibitor for the treatment of diabetes does not increase the risk of inflammatory bowel disease

DPP4 Inhibitors Do Not Up Risk of Inflammatory Bowel Disease

Findings based on comparison to sulfonylureas, thiazolidinediones
For patients with mental health or substance use disorders with newly diagnosed diabetes

Primary Care Use Aids Patients With Diabetes and Coexisting Psych Disorders

More primary care for patients with mental health, substance use disorders may affect diabetes severity
The Affordable Care Act provided care to an estimated 1.9 million people with diabetes

ACA Provided Care to 1.9 Million People With Diabetes

Adjusted uninsured rates down 17 percent for people with undiagnosed diabetes after ACA
There is a strong association between 25-hydroxyvitamin D deficiency (<50 nmol/L) and increased mortality

Vitamin D Deficiency Linked to Increased Mortality

Association strongest in younger and middle-aged groups and for diabetes-related deaths
Living through a hurricane increases both the short- and long-term risk for death among seniors with diabetes

Hurricanes Up Mortality Risk for Seniors With Diabetes

In the first month after Katrina and Rita, all-cause mortality spiked 40 percent among seniors with diabetes
Use of sodium glucose cotransporter 2 inhibitors for type 2 diabetes is associated with a reduced risk for heart failure

SGLT2 Inhibitors Linked to Lower Risk for Heart Failure

Risk lower for HF, but not major CV events, compared with new users of DPP4 inhibitors
Even at lower body weights

Rates of Diabetes Higher at Lower BMIs Among Minorities

At normal body weight, rates for diabetes three times higher in Hawaiians, Pacific Islanders
In a large university population

Diabetes Distress Common at Large Midwestern University

Findings based on survey of university-affiliated students, staff with either type 1 or type 2 diabetes
In updated guidelines developed by the European Society of Cardiology

ESC Guidelines Updated for Managing CVD in Diabetes

Guidelines address lifestyle recommendations, individualized BP targets, SGLT2 inhibitor, GLP1-RA tx